Leukemia Drug Treats MS

This is good news to the 500,000 people in Britain and the United States who suffers MS or Multiple sclerosis. According to the researchers of the University of Cambridge, they have discovered that the medicine used in treating Leukemia can halt and even reverse the effects of multiple sclerosis (MS).

The said drug is alemtuzumab. According to Wikipedia, "Alemtuzumab is indicated for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and who have failed fludarabine therapy."

Based on the clinical trial, alemtuzumab reduced the number of attacks in sufferers by 74%. It also helped patients in recovering lost functions and repairing damaged brain tissues.

According to Dr. Alasdair Coles, a lecturer at Cambridge University's (Department of Clinical Neurosciences), "The ability of an MS drug to promote brain repair is unprecedented. We are witnessing a drug which, if given early enough, might effectively stop the advancement of the disease and also restore lost function by promoting repair of the damaged brain tissue."

Multiple sclerosis (MS) also known as disseminated sclerosis or encephalomyelitis disseminata affects areas of the brain and the spinal cord. MS destroys the fatty layer that wraps around our nerve fibers. When this happens, the axons of neurons can no longer effectively conduct cognitive and physical actions.

Currently, there is no known cure for MS. I just hope this drug can be a miracle for MS patients.

If you like this post, buy me a cup of coffee.